###begin article-title 0
Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains
###end article-title 0
###begin p 1
###xml 93 115 93 115 <email xmlns:xlink="http://www.w3.org/1999/xlink">r.kuiper@antrg.umcn.nl</email>
To whom correspondence should be addressed. Tel: +31 24 3614017; Fax: +31 24 3540488; Email: r.kuiper@antrg.umcn.nl
###end p 1
###begin p 2
###xml 437 441 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF</italic>
###xml 462 466 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 471 475 471 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 622 626 622 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 723 727 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 740 746 740 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-C</italic>
###xml 962 966 962 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 330 335 <span type="species:ncbi:9606">human</span>
The MiTF/TFE (MiT) family of basic helix-loop-helix leucine zipper transcription factors is composed of four closely related members, MiTF, TFE3, TFEB and TFEC, which can bind target DNA both as homo- or heterodimers. Using real-time RT-PCR, we have analyzed the relative expression levels of the four members in a broad range of human tissues, and found that their ratio of expression is tissue-dependent. We found that, similar to the MiTF gene, the genes for TFEB and TFEC contain multiple alternative first exons with restricted and differential tissue distributions. Seven alternative 5' exons were identified in the TFEB gene, of which three displayed specific expression in placenta and brain, respectively. A novel TFEC transcript (TFEC-C) encodes an N-terminally truncated TFEC isoform lacking the acidic activation domain (AAD), and is exclusively expressed in kidney and small intestine. Furthermore, we observed that a considerable proportion of the TFEC transcripts splice out protein-coding exons, resulting in transcription factor isoforms lacking one or more functional domains, primarily the basic region and/or the AAD. These isoforms were always co-expressed with the intact transcription factors and may act as negative regulators of MiTF/TFE proteins. Our data reveal that multiple levels of regulation exist for the MiTF/TFE family of transcription factors, which indicates how these transcription factors may participate in various cellular processes in different tissues.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c1">1</xref>
###xml 298 306 298 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c1">1</xref>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c3">3</xref>
The basic helix-loop-helix leucine zipper (bHLH-LZ) transcription factors MiTF, TFE3, TFEB and TFEC comprise a family (MiTF/TFE or MiT family) of closely related proteins that bind DNA as homo- and heterodimers (1). All possible combinations of DNA-binding MiTF/TFE dimers have been shown to exist in vitro (1-3).
###end p 4
###begin p 5
###xml 282 283 282 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c4">4</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c5">5</xref>
###xml 408 409 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c6">6</xref>
###xml 410 411 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c7">7</xref>
###xml 436 437 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c8">8</xref>
###xml 501 502 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c9">9</xref>
###xml 503 505 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c11">11</xref>
###xml 562 566 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFE3</italic>
###xml 571 575 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 746 748 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c12">12</xref>
###xml 749 751 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c19">19</xref>
###xml 643 651 <span type="species:ncbi:9606">children</span>
The members of this family are believed to be implicated in pivotal developmental and cellular processes in various cell types. MiTF is involved in the maturation of melanocytes of neural crest origin, retinal pigment epithelium, and bone marrow-derived mast cells and osteoclasts (4); whereas TFEB is essential for placental vascularization (5). TFE3 plays a role in TGF-beta-activated signal transduction (6,7) and B-cell activation (8), and cooperates with MiTF and TFEC in osteoclast development (9-11). Furthermore, chromosomal translocations involving the TFE3 and TFEB genes have been implicated in subtypes of renal cell carcinomas in children and young adults. In addition, TFE3 rearrangements were found in alveolar soft part sarcomas (12-19).
###end p 5
###begin p 6
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c3">3</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c20">20</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c21">21</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c11">11</xref>
###xml 843 850 843 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c10">10</xref>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c21">21</xref>
###xml 937 939 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c22">22</xref>
The apparent distinctive cellular functions of MiTF/TFE family members in the various cell types require regulatory mechanisms that tightly control MiTF/TFE functioning. Such mechanisms may involve interactions with cell type-specific factors or specific protein modifications, but the relative levels of co-expression of the various transcription factors may be important as well. Indeed, the expression levels of each of the four MiTF/TFE family members appear to differ considerably between cell types (3,20,21), which points towards a model in which the ratio of MiTF/TFE expression dictates specific dimerization patterns and, subsequently, the expression of target genes. Although there are indications that heterodimeric interactions are not essential for proper MiTF/TFE functioning (11), MiTF-TFE3 and MiTF-TFEC heterodimers do exist in vivo, and are believed to be involved in the regulation of cell type-specific genes (10,21,22).
###end p 6
###begin p 7
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF</italic>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c23">23</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c24">24</xref>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c4">4</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c21">21</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c24">24</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c28">28</xref>
The MiTF gene is expressed in different isoforms that are under the control of distinct promoters (23,24). Currently, at least eight major MiTF isoforms have been identified that are differentially expressed in a variety of tissues, including melanocytes, heart and mast cells (4,21,24-28). These isoforms share the important functional domains of MiTF, including the transactivation domain, basic region, helix-loop-helix and leucine zipper, but differ in their N-termini. These N-termini may contribute to the cell type-specific properties of the various isoforms, for example by recruiting particular cofactors to the transcription apparatus. Thus far, little is known about the tissue distribution of the other three MiTF/TFE family members TFE3, TFEB and TFEC.
###end p 7
###begin p 8
###xml 114 119 <span type="species:ncbi:9606">human</span>
In this study, we have determined the relative expression levels of MiTF, TFE3, TFEB and TFEC in a broad range of human tissues, and identified transcript variants. The ratio of expression of the four MiTF/TFE family members was found to be unique for each tissue. Furthermore, similar to MiTF, we found various splice forms of TFEB and TFEC with alternative first exons and very restricted expression patterns, suggesting regulation through alternative promoter usage.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
cDNA synthesis and RT-PCR
###end title 10
###begin p 11
###xml 35 40 <span type="species:ncbi:9606">human</span>
A panel of total RNA pools from 20 human tissues was obtained from BD Biosciences Clontech (Palo Alto, CA). Reverse transcription was performed using 2 microg of total RNA and Superscript II (Life Technologies, Grand Island, NY) according to the manufacturer's instructions. RT reactions were performed using random hexamers, except for the experiment dealing with alternative intron 7 splicing of TFEC transcripts, for which oligo-dT priming was used in order to minimize contamination with incompletely spliced nuclear mRNAs. Primers used for PCR were TFEB-1Af (5'-CAAC AAGGGAAGGTGACATGAAAGG-3'), TFEB-1Bf (5'-CG GACAGATTGACCTTCAGAGG-3'), TFEB-1C1for (5'-AT GCCTGAGAGGGGGTCGGAG-3'), TFEB-1C2for (5'-GA GAGGAGGGAGATGAAAACACACC-3'), TFEB-1Df (5'-TTAGAGCTCGCTGGGGAAGTGCAG-3'), TFEB-1Ef (5'-TTGAGGTCCCTGCCTGCTAACCTGACG-3'), TFEB-1Ff (5'-CCTCCTTCCAGGGGGCTGCC-3'), TFEB-1Gf (5'-GG TGTGAGCTGACGAGAGCTTCAG-3'), TFEBexon2r (5'-AACCCTATGCGTGACGCCATGGTGG-3'), TFEC-1Af (5'-ACTTGTCCCAGCAAGACCACA-3'), TFEC-1Bf (5'-AAATCCACTCATTGCTGGTCC-3'), TFEC-1Cf (5'-GAG AAAACCATTGCTATTGTGAAGG-3'), TFECr (5'-TTGT AGCCACTTGATGTACTCCACT-3'), TFEC-6f (5'-CACT CTTATTCCAAAGTCTAATGATCCT-3'), TFECintron7r (5'-CCTTGAGGCAATGAAATCCATAGC-3') and TFEC-8r (5'-TCTTTGTTCCTCTTTCAATGCAGC-3').
###end p 11
###begin title 12
Real-time quantitative RT-PCR
###end title 12
###begin p 13
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF/TFE</italic>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c18">18</xref>
###xml 290 298 290 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF/TFE</italic>
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFE3</italic>
###xml 442 446 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 456 460 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF</italic>
###xml 515 523 515 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF/TFE</italic>
###xml 609 613 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 615 616 615 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 663 668 663 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 704 709 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
###xml 772 773 764 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 785 787 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c29">29</xref>
###xml 698 703 <span type="species:ncbi:9606">human</span>
Real-time RT-PCR on MiTF/TFE cDNAs was performed on a TaqMan ABI 7700 Sequence Detection System (PE Applied Biosystems) using heat-activated TaqDNA polymerase (Amplitaq Gold; PE Applied Biosystems) as previously described (18). The specificity of the primer/probe sets for each of the four MiTF/TFE members relative to the other three was confirmed using different dilutions of DNA constructs containing the bHLH-LZ-encoding regions of TFE3, TFEB, TFEC or MiTF. The four primer/probe sets recognized their specific MiTF/TFE templates with almost identical efficiencies. For quantitative analysis of the data, TFEB CT-values were normalized to those of endogenous GAPDH (with use of standard TaqMan human GAPDH control reagents; PE Applied Biosystems) using the DeltaDeltaCT technique (29).
###end p 13
###begin title 14
Rapid amplification of 5'-cDNA ends (5'-RACE)
###end title 14
###begin p 15
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 416 420 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
The 5'-RACE System (Invitrogen) was used according to the manufacturer's instructions. A TFEB gene-specific primer (5'-ATTTCAGGATTGATGTAGC-3') was used for TFEB cDNA synthesis. The TFEB-specific primers (located in exon 2) were TFEB 5'R442 (5'-TATTGATGGCCGGGGTGGGCG-3') and TFEB 5'R376 (5'-TAATGCATGACAGCCTGTTGCT GCATG-3'), of which the latter was used for the hemi-nested reaction. For the TFEC 5'-RACE we used the TFEC gene-specific primer (5'-TTTCAATGAGGTTGTGG-3') for cDNA synthesis and primers TFEC 5'R547 (5'-ATTGGTA GACTACTTGGACAAGAAGCAC-3') and TFEC 5'R494 (5'-AATTCCTTGTTCACCGCTATACACATCC-3') for the PCR. The PCR profile was composed of five cycles of 30 s at 94degreesC, 1 min at 48degreesC, 30 s at 72degreesC; five cycles of 30 s at 94degreesC, 1 min at 52degreesC, 30 s at 72degreesC; 25 cycles of 30 s at 94degreesC, 1 min at 55degreesC, 30 s at 72degreesC. PCR products were separated on agarose gels, purified, subcloned into the pGemT vector (Promega, Leiden, The Netherlands), and subsequently sequenced using a Ready Reaction Dye Terminator Cycle sequencing kit (PE Applied Biosystems, Foster City, CA) and an ABI 3700 automated sequencer (PE Applied Biosystems).
###end p 15
###begin title 16
Transfection experiments and western blotting
###end title 16
###begin p 17
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c30">30</xref>
###xml 154 158 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c18">18</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c18">18</xref>
###xml 337 343 <span type="species:ncbi:9986">rabbit</span>
###xml 435 440 <span type="species:ncbi:10090">mouse</span>
Full-length RT-PCR products corresponding to the wild-type TFEB and TFEC transcripts were cloned into the eukaryotic expression vector pSG8-VSV (30). The TFEC cDNAs were cloned in-frame in front of a VSV-tag. Transfection and western blotting was performed as previously described (18). For immunodetection of TFEB, an affinity-purified rabbit polyclonal anti-TFEB-N antiserum was used (18). The VSV-tagged TFEC was detected using the mouse anti-VSV monoclonal antibody P5D4. Immunostaining was performed using chemiluminesence.
###end p 17
###begin title 18
RESULTS
###end title 18
###begin title 19
The MiTF/TFE transcription factor family shows a specific tissue distribution
###end title 19
###begin p 20
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c1">1</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f1">1</xref>
###xml 623 631 623 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF/TFE</italic>
###xml 743 744 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f1">1</xref>
###xml 834 842 834 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF/TFE</italic>
###xml 955 959 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 964 968 964 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF</italic>
###xml 1027 1028 1027 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f1">1</xref>
###xml 1066 1070 1066 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFE3</italic>
###xml 1075 1079 1075 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 1188 1192 1188 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFE3</italic>
###xml 1237 1241 1237 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 1244 1248 1244 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF</italic>
###xml 1287 1291 1287 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 438 443 <span type="species:ncbi:9606">human</span>
In vitro, TFE3, TFEB, TFEC and MiTF form homo- and heterodimers in all possible combinations to bind DNA (1). Based on this observation, it can be hypothesized that differential tissue-specific dimerization may determine the repertoire of target genes that are expressed. In order to analyze the relative expression levels of the MiTF/TFE members in different tissues, we performed quantitative real-time RT-PCR analysis on a panel of 20 human tissues. We established primer sets located within the bHLH-encoding regions, capable of detecting all MiTF/TFE isoforms. As shown in Figure 1A, the expression ratios of the four MiTF/TFE members showed large variations between tissues and none of the members appeared to be co-regulated. In Figure 1B, the same set of data is represented as absolute levels, which allows comparison of the MiTF/TFE expression levels between tissues. Although each of the four members could be detected in all tissues examined, TFEC and MiTF showed more variation in expression between tissues (Fig. 1B). Highest expression levels of both TFE3 and TFEB were found in placenta and lung, but their expression levels differed in adrenal gland (relatively high for TFE3), and prostate and spleen (higher levels of TFEB). MiTF was most prominent in the uterus. The TFEC gene was expressed at lower levels compared to the other three members, and was prominent in spleen, kidney, bone marrow and small intestine. These data indicate that expression of each of the four members must be regulated in a tissue-specific manner.
###end p 20
###begin title 21
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
The TFEB gene contains alternative 5'-non-coding exons
###end title 21
###begin p 22
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF</italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c24">24</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c26">26</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c28">28</xref>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c18">18</xref>
###xml 743 747 743 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 958 962 958 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 1078 1079 1078 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh571tb1">1</xref>
###xml 1089 1090 1089 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f2">2</xref>
###xml 1140 1146 1140 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-A</italic>
###xml 1150 1156 1150 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-G</italic>
###xml 1176 1182 1176 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-B</italic>
###xml 1184 1186 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c31">31</xref>
###xml 1192 1198 1192 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-C</italic>
###xml 1285 1289 1285 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 1356 1357 1356 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh571tb1">1</xref>
###xml 1443 1449 1443 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-G</italic>
###xml 1570 1571 1570 1571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f2">2</xref>
###xml 1583 1584 1583 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh571tb1">1</xref>
###xml 1619 1625 1619 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-E</italic>
###xml 1751 1752 1751 1752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f2">2</xref>
###xml 1776 1782 1776 1782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-E</italic>
###xml 1844 1848 1844 1848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 1982 1988 1982 1988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-C</italic>
###xml 2013 2014 2013 2014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f2">2</xref>
###xml 2276 2280 2276 2280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
The temporal and spatial expression of the human MiTF gene is controlled by the differential usage of at least six distinct promoters, driving the expression of transcripts with alternative first exons (24-26,28). We investigated whether a similar mechanism might act in the other MiTF/TFE members. The TFEB gene, which resides on chromosome 6p21, is composed of nine exons, with a postulated initiation ATG preceded by a perfect ribosomal binding ('Kozak') sequence in exon 2 (18). The numerous TFEB-encoding ESTs that are present in the nucleotide sequence databases reveal the presence of at least three frequently occurring alternative 5' exons (GenBank Accession nos M33782, NM007162 and AK095061, respectively). To validate whether more TFEB transcripts might exist that differ in their 5'-end, we performed 5'-RACE analysis on cDNA pools of various tissues, using TFEB-specific primers located in exon 2. Using this approach, we were able to identify TFEB transcripts containing seven distinct alternative 5' exons, of which five were novel, named exons 1a to 1g1 (Table 1 and Fig. 2). The resulting TFEB transcripts were designated TFEB-A to TFEB-G, respectively. The TFEB-B (31) and TFEB-C transcripts were found in liver, kidney, spleen and brain, whereas the remaining five TFEB transcripts were found in only one of the tissues examined (Table 1). In addition, we observed three alternative splicing events in the 5' region of the TFEB-G transcripts, generating transcripts containing either 1g1 alone, 1g1/1g2 or the complete exon 1g at their 5'-ends (Fig. 2B and Table 1). Similarly, we found alternative TFEB-E splice variants in the brain cDNA pool which contained exon 1c2 and, in some cases, the entire sequence from 1e to 1c2 (Fig. 2B). This latter longest TFEB-E variant corresponds to the previously identified full-length TFEB transcript AK095061. Another 5'-RACE product, obtained from skeletal muscle cDNA, appeared to be an alternatively spliced variant of TFEC-C, lacking exon 1c2 (Fig. 2B). Of all alternative 5' exons, only exon 1a contains a putative in-frame ATG codon which, if active, would result in 14 extra N-terminal amino acids in TFEB-A. Therefore, most alternative 5' exons are non-coding. Together, we conclude from these data that the TFEB gene contains multiple alternative first exons.
###end p 22
###begin title 23
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
Differential tissue distribution of alternative TFEB transcripts
###end title 23
###begin p 24
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 302 303 302 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f2">2</xref>
###xml 312 318 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-D</italic>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkh571tb1">1</xref>
###xml 523 529 523 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-D</italic>
###xml 638 644 638 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-B</italic>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-C</italic>
###xml 702 708 702 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-C</italic>
###xml 767 773 767 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-A</italic>
###xml 902 908 902 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-E</italic>
###xml 913 919 913 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-G</italic>
###xml 971 977 971 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-F</italic>
###xml 1006 1007 1006 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f2">2</xref>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 116 121 <span type="species:ncbi:9606">human</span>
To analyze the relative expression of the above TFEB variants in human tissues, we performed RT-PCR analysis on the human tissue panel using alternative exon 1-specific primers for the various transcripts. Six TFEB transcripts showed restricted and clearly different tissue distribution patterns (Fig. 2C). Only TFEB-D could not be amplified in any of the tissues, possibly due to very low expression levels. Despite the fact that the splice acceptor site of exon 1d perfectly matches the consensus criteria (Table 1), the TFEB-D transcript was found only once in our 5'-RACE analysis, and its existence thus still needs to be confirmed. TFEB-B and TFEB-C showed the broadest tissue distribution, with TFEB-C being detectable in all tissues but liver. Interestingly, TFEB-A was almost exclusively expressed in placenta, with only minor levels of expression in kidney, lung and prostate. Similarly, the TFEB-E and TFEB-G transcripts appeared to be brain-specific, whereas TFEB-F was highest in spleen (Fig. 2C).
###end p 24
###begin p 25
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f2">2</xref>
###xml 707 711 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOS1</italic>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c32">32</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c33">33</xref>
The multiple RT-PCR products observed in the TFEB-E and TFEB-G panels were isolated and sequenced, and appeared to correspond to the splice variants identified with 5'-RACE analysis (Fig. 2B). Based on the intensities of these products in the two panels, these splice variants appear to be expressed in a tissue-specific manner. Despite their differential tissue distribution, none of these variants contain upstream ATG start codons, indicating that they all encode TFEB proteins with identical N-termini. Variations in the 5'-UTR sequences might, however, influence the efficiency of translation, as has been described for the cyclin-dependent kinase inhibitor p18INK4c and the nitric oxide synthase gene NOS1 (32,33). We conclude that alternative transcripts may control the expression of TFEB in a tissue-specific manner.
###end p 25
###begin title 26
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
Differential tissue distribution of TFEC variants
###end title 26
###begin p 27
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 23 24 23 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f3">3</xref>
###xml 145 151 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-A</italic>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-B</italic>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 305 311 305 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-A</italic>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f3">3</xref>
###xml 531 535 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 638 639 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f3">3</xref>
###xml 861 867 861 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-C</italic>
###xml 998 1004 998 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-C</italic>
###xml 1192 1193 1180 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f3">3</xref>
###xml 1199 1205 1187 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-C</italic>
###xml 490 495 <span type="species:ncbi:9606">human</span>
###xml 1239 1244 <span type="species:ncbi:10090">mouse</span>
In the TFEC gene (Fig. 3), at least two alternative transcription start sites appear to be present, resulting in transcripts here referred to as TFEC-A and TFEC-B (GenBank Accession nos BM807021 and NM012252, respectively). Exon 2 is shared by the two TFEC variants, and contains the ATG start codon. The TFEC-A variant has not been described before, and contains three exons preceding exon 2. Two additional in-frame ATG codons are present in exon 1a3 (Fig. 3A). Using 5'-RACE analysis on human kidney cDNA, we identified a third TFEC transcript, which initiates in an alternative 5' exon positioned between exons 3 and 4 (exon 1c; Fig. 3A). RT-PCR analysis using a reverse primer in exon 1c in combination with a forward primer in any of the upstream exons never resulted in a PCR product, indicating that exon 1c is indeed the first exon of this transcript. TFEC-C thus lacks the protein-coding exons 2 and 3. In-frame ATG start codons were present in both exon 1c and exon 4. Subcloning of the TFEC-C cDNA in front of an in-frame VSV-tag, and subsequent transfection into COS-1 cells, revealed that the transcript indeed encodes a protein of the predicted size (approximately33 kDa; Fig. 3B). A TFEC-C transcript was also found in the mouse (Genbank Accession no. BB843583), and appeared to be highly conserved at both the nucleotide (83%) and amino acid (86%) level.
###end p 27
###begin p 28
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f3">3</xref>
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-A</italic>
###xml 179 185 179 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-B</italic>
###xml 306 312 306 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-C</italic>
Similar to TFEB, the tissue distributions of TFEC transcripts was analyzed by RT-PCR (Fig. 3C). TFEC-A was predominantly expressed in testis, thymus, trachea, colon and prostate. TFEC-B showed a broader tissue distribution, and appeared to be absent only from heart and liver, whereas the newly identified TFEC-C transcript was exclusively expressed in kidney and small intestine.
###end p 28
###begin p 29
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF</italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
Together, these findings suggest that next to the MiTF gene, the TFEB and TFEC genes also express transcripts with alternative 5' exons that show restricted and clearly distinct tissue distributions.
###end p 29
###begin p 30
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF</italic>
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFE3</italic>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFE3</italic>
###xml 161 166 <span type="species:ncbi:9606">human</span>
Unlike MiTF, TFEB and TFEC, there are no TFE3 transcripts known that would indicate the presence of alternative first exons. Furthermore, RT-PCR analysis on the human tissue panel, using a primer set that included the first exon and a primer set located within the bHLH domain, gave identical tissue distributions (data not shown). Therefore, we assume that expression of the TFE3 gene is regulated by a single promoter.
###end p 30
###begin title 31
Alternative splicing of exons encoding functional domains
###end title 31
###begin p 32
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f3">3</xref>
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-A</italic>
###xml 601 607 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-A</italic>
###xml 694 698 686 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 863 869 835 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-A</italic>
###xml 952 958 924 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-B</italic>
###xml 971 972 943 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f3">3</xref>
###xml 1092 1098 1064 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-L</italic>
###xml 1110 1116 1082 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-S</italic>
###xml 1140 1142 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c34">34</xref>
###xml 1329 1335 1301 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-C</italic>
RT-PCRs with 5' exon-specific primers generated multiple bands in all cases (Fig. 3C), which indicates that from each transcription start site various alternative transcripts can be generated. To reveal their identity, we have isolated and sequenced these different products. The largest RT-PCR product in the TFEC-A panel represents a transcript containing all protein-coding exons, whereas the lower band was found to lack the N-terminal acidic activation domain (AAD)-encoding exon 3 and the basic region-encoding exon 5 (Delta3/Delta5). In testis, the tissue that showed the highest expression of TFEC-A, two minor additional products could be isolated as well, and turned out to represent TFEC transcripts lacking exons 2 and 3 (Delta2/Delta3) and exons 2, 3 and 5 (Delta2/Delta3/Delta5), respectively. Interestingly, the relative expression ratios of these TFEC-A variants was different between the various tissues. Similarly, the doublet in the TFEC-B panel (Fig. 3C) appeared to represent transcripts that differ in the presence or absence of exon 3, and were previously presented as TFEC-L (long) and TFEC-S (short), respectively (34). Apparently, these two forms are mostly co-expressed, although the ratio in each of the tissues examined was different. Finally, we also detected a weakly expressed, smaller variant of TFEC-C, which differed from the major form in that it again lacked the basic region-encoding exon 5 (Delta5).
###end p 32
###begin p 33
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c35">35</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c36">36</xref>
###xml 644 648 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 888 889 888 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkh571f3">3</xref>
###xml 1043 1047 1043 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
Apart from exon 3 and exon 5, we found indications for another frequently occurring alternative splicing event in the TFEC gene. This alternative splicing event involves the C-terminus of TFEC, which became apparent when we used a reverse RT-PCR primer positioned in exon 8, the 3'-terminal exon of the gene. The C-terminal region of the protein is highly conserved within the MiTF/TFE family and contains two functional domains, namely a proline-rich activation domain (35), and a serine-rich region that contains an Rsk-1 phosphorylation site that is known to play a role in transactivation and degradation of MiTF (36). In most, if not all, TFEC expressing tissues, transcripts could be detected in which intron 7 is still present. Translation of such a transcript would result in a truncated TFEC protein that lacks the proline-rich activation domain and the serine-rich domain (Fig. 3C, two bottom panels). Although the RT-PCRs were performed under semi-quantitative conditions, it appears that the presence or absence of intron 7 in the TFEC transcripts again varies between tissues.
###end p 33
###begin p 34
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 293 297 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
The expression of alternatively spliced variants of TFEB was less apparent than that of TFEC. The TFEB variants were mainly expressed as full-length transcripts that contained an alternative exon 1 followed by the protein-encoding exons 2 to 9. Nevertheless, we did find alternatively spliced TFEB transcripts in a limited set of tissues lacking exon 3 and exon 4, of which the latter encodes the AAD (data not shown).
###end p 34
###begin p 35
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 79 84 <span type="species:ncbi:9606">human</span>
In conclusion, we have established MiTF/TFE expression levels and ratios in 20 human tissues. These expression patterns appeared to be unique for each tissue. Furthermore, we identified (novel) alternative 5' exons in the proximal regions of the TFEB and TFEC genes, and demonstrated that the expression of MiTF/TFE isoforms lacking functional domains is a characteristic for all members of the family, but is predominant for TFEC.
###end p 35
###begin title 36
DISCUSSION
###end title 36
###begin p 37
###xml 473 477 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF</italic>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c4">4</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c21">21</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c24">24</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c28">28</xref>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 999 1005 999 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-E</italic>
###xml 1247 1249 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c37">37</xref>
###xml 1296 1300 1296 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 1523 1527 1523 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 1532 1536 1532 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 119 124 <span type="species:ncbi:9606">human</span>
###xml 849 854 <span type="species:ncbi:9606">human</span>
###xml 1160 1165 <span type="species:ncbi:9606">human</span>
###xml 1170 1175 <span type="species:ncbi:10090">mouse</span>
###xml 1230 1235 <span type="species:ncbi:9606">human</span>
We have determined the expression profile of the MiTF/TFE family of bHLH-LZ transcription factors in a large series of human tissues and identified alternative transcripts generated by the respective genes. We found that the ratio in which these four members are expressed differs extensively between the various tissues examined. The tight spatial regulation of MiTF/TFE expression appears to be mediated at least in part by alternative transcription start sites. Next to MiTF (4,21,24-28), both TFEB and TFEC were found to express a variety of transcripts that contain alternative 5' (non-coding) exons and show very restricted differential tissue distributions. The use of alternative 5' exons in a tissue-specific manner point towards the existence of alternative promoters in both genes. Indeed, through the characterization of an oligo-capped human cDNA library, the exact position of the transcription start site and thereby the position of a core-promoter region has been identified for the TFEB-E transcript (see ). Furthermore, three more downstream located exons (1b, 1c1 and 1d) are positioned within a 1600-bp CpG island that is conserved between human and mouse. Such regions are known to colocalize with 60% of the human promoters (37). Although we cannot exclude that some of the TFEB variants we found are the result of alternative transcription start site usage within a single promoter region or alternative splicing in the 5'-UTR, our data strongly suggests the presence of alternative promoters in the TFEB and TFEC genes.
###end p 37
###begin p 38
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-A</italic>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 459 463 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 477 483 477 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-E</italic>
###xml 488 494 488 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-G</italic>
###xml 550 556 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-A</italic>
###xml 806 807 806 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c5">5</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c11">11</xref>
###xml 848 852 848 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 1067 1071 1067 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 1131 1135 1131 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 1201 1207 1201 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-C</italic>
###xml 1301 1305 1301 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 1316 1320 1316 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 1370 1374 1370 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 1422 1426 1422 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MiTF</italic>
###xml 1447 1451 1447 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 1456 1460 1456 1460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 1917 1919 1917 1919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c18">18</xref>
###xml 623 638 <span type="species:ncbi:10090">transgenic mice</span>
###xml 898 903 <span type="species:ncbi:9606">human</span>
We identified seven alternative 5' exons in the TFEB gene. Except for TFEB-A, all these 5' exons appeared to be non-coding, suggesting that the respective transcripts encode the same TFEB protein. Together, the TFEB transcripts drive the ubiquitous expression of TFEB. However, each transcript was represented in a restricted set of tissues, and we found three novel TFEB transcripts that were predominantly expressed in one particular tissue. Of these three TFEB transcripts, TFEB-E and TFEB-G appeared to be specifically abundant in brain, whereas TFEB-A was expressed almost exclusively in placenta. Previous studies in transgenic mice already revealed that TFEB, but not the other MiTF/TFE members, plays an essential role in placental vascularization during the early stages of placental development (5,11). Our finding of a placenta-enriched TFEB variant points towards a similar role in the human placenta. This placental expression of TFEB appears to be controlled by a distinct promoter. A total of three alternative 5' exons were found to be present in the TFEC gene, of which two (exons 1a and 1c) were novel. The three TFEC transcripts were all expressed in a limited set of tissues, with TFEC-C being exclusively found in kidney and small intestine. Despite this restricted expression of TFEC variants, TFEC was observed in all tissues examined, similar to TFEB. From these data, we conclude that next to the MiTF gene, the genes for TFEB and TFEC are also equipped with different alternative first exons and multiple promoter regions. Such a genomic organization allows a tightly regulated expression of the respective transcription factors in a cell type-specific manner, and may explain the observed tissue-specific ratios of the four MiTF/TFE members. These relative expression levels may affect MiTF/TFE homo- or heterodimerization and, thereby, influence the regulation of downstream target genes (18).
###end p 38
###begin p 39
###xml 556 562 556 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-A</italic>
###xml 564 570 564 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-B</italic>
###xml 575 581 575 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-C</italic>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c35">35</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c38">38</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c23">23</xref>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c36">36</xref>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c39">39</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c23">23</xref>
###xml 1096 1098 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c40">40</xref>
###xml 1099 1101 1099 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c41">41</xref>
###xml 1809 1812 1809 1812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p63</italic>
###xml 1817 1820 1817 1820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p73</italic>
###xml 1841 1844 1841 1844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53</italic>
###xml 1973 1975 1973 1975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c42">42</xref>
###xml 1976 1978 1976 1978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c43">43</xref>
###xml 2107 2109 2107 2109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c43">43</xref>
###xml 2110 2112 2110 2112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c45">45</xref>
###xml 2273 2275 2273 2275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c42">42</xref>
###xml 2276 2278 2276 2278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkh571c46">46</xref>
###xml 2665 2669 2665 2669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
Another important mechanism for functional regulation may be the co-expression of MiTF/TFE members with isoforms lacking particular functional domains. Co-expression of such isoforms appears to occur for all MiTF/TFE proteins, but was most evident for TFEC. Multiple splice variants, lacking exons encoding a conserved mitogen-activated protein kinase (MAPK) phosphorylation site (exon 2), the N-terminal AAD (exon 3), the basic region (exon 5), and/or the C-terminal proline-rich activation domain and serine-rich stretch (exon 8), were co-expressed with TFEC-A, TFEC-B and TFEC-C. These domains are highly conserved in the MiTF/TFE family members and all play a role in the transactivating capacities of the proteins. Therefore, these isoforms may act as weaker transactivators or even repressors, as has been shown for TFE3 (35,38) and MiTF (23,36,39). Furthermore, splice variants lacking the basic region have been described for MiTF as well (23), and may act as negative regulators by forming non-DNA-binding homo- or heterodimers similar to what has been proposed for the HLH Id proteins (40,41). The N-terminally truncated TFEC-C isoform appears to be expressed from an internal promoter, and also lacks the MAPK phosphorylation site and the AAD. Remarkably, this isoform was exclusively expressed in kidney and small intestine, which might indicate that it is involved in the regulation of processes that are shared by these two tissues, like for example (re)absorption of ions and/or organic compounds. The co-expression of these different TFEC isoforms may allow fine regulation of MiTF/TFE activities, and may be crucial for the proper spatio-temporal functioning of these transcription factors. Other well-characterized examples of genes that produce multiple isoforms with a regulatory role are p63 and p73, two members of the p53 gene family. Both genes produce splice variants as well as N-terminally truncated forms that originate from internal promoters (42,43). These isoforms act as dominant-negative regulators of p63, p73 and their close relative p53 by forming heteromeric complexes (43-45). The truncated isoforms were found to be vital for normal growth and development, and provide a regulatory system for modulating cell survival and cell death (42,46). Based on our findings, we hypothesize that the various MiTF/TFE isoforms lacking functional domains may form heterodimers with the full-length counterparts and, thereby, modulate their role in downstream target gene regulation, either by preventing DNA binding, changing the DNA-binding specificity, or altering the binding capacities of transcriptional cofactors. In particular, the TFEC gene, which generates the widest variety of functionally distinct isoforms, may play a prominent role in such regulatory mechanisms.
###end p 39
###begin title 40
Figures and Tables
###end title 40
###begin p 41
###xml 148 149 148 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 300 301 300 301 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 99 104 <span type="species:ncbi:9606">human</span>
 Bar graphs showing the relative expression levels of the MiTF/TFE transcription factors in twenty human tissues, as analyzed by real-time RT-PCR. (A) The sum of the expression levels of TFE3, TFEB, TFEC and MiTF is set to 100% to enable comparison of the MiTF/TFE expression ratios in each tissue. (B) The same data set depicted as absolute levels to illustrate the variation in MiTF/TFE expression between tissues. The data were based on two independent in duplo experiments.
###end p 41
###begin p 42
###xml 2 3 2 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 244 245 244 245 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 294 300 294 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-C</italic>
###xml 302 308 302 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-E</italic>
###xml 313 319 313 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-G</italic>
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB-G</italic>
###xml 587 588 587 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 623 627 623 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 617 622 <span type="species:ncbi:9606">human</span>
###xml 673 678 <span type="species:ncbi:9606">human</span>
 (A) The genomic organization of the human TFEB gene. The ATG start codon in exon 2 and TAG stop codon in exon 9 are indicated. Dotted lines depict alternative splicing. A 1600-bp CpG island colocalizes with exons 1b, 1c1 and part of exon 1d. (B) Alternative splice events in the 5'-regions of TFEB-C, TFEB-E and TFEB-G. Dotted lines depict alternative splicing. The largest of three TFEB-G derived products contained the complete exon 1g, including 1g1, 1g2 and the intermediate 'intronic' sequence. Accession numbers of the nine novel TFEB transcript fragments are AJ608786-AJ608794. (C) Tissue distribution of the human TFEB variants determined by RT-PCR analysis on 20 human tissues.
###end p 42
###begin p 43
###xml 2 3 2 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 448 454 448 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-C</italic>
###xml 489 490 489 490 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 582 588 582 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC-C</italic>
###xml 605 606 605 606 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 635 639 635 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 786 790 786 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 1074 1078 1062 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEC</italic>
###xml 37 42 <span type="species:ncbi:9606">human</span>
 (A) Schematic representation of the human TFEC gene containing three alternative 5' exons. For clarity reasons, exon sizes are depicted five times larger than the intron sizes. Relevant start and stop codons are indicated, as well as the regions encoding the AAD, the basic region, the bHLH-LZ and the proline-rich activation domain and serine-rich stretch (Pro-AD/Ser). Dotted lines depict alternative splicing. The accession number of the novel TFEC-C transcript fragment is AJ608795. (B) Western blot analysis of COS-1 cells transfected with empty vector (lane 1) or VSV-tagged TFEC-C cDNA (lane 2). (C) Tissue distribution of the TFEC transcripts determined by RT-PCR analysis. For each of the panels, the various PCR fragments were isolated and sequenced. Next to the full-length TFEC variants, alternatively spliced transcripts were amplified that lacked exon 2 (Delta2), exon 3 (Delta3) and/or exon 5 (Delta5). The lower two panels show RT-PCR products using a forward primer in exon 6, and reverse primers in either exon 8 or intron 7, which depict the presence of TFEC transcripts encoding the complete C-terminus of TFEC or a truncated C-terminus, respectively. In order to enrich for active cytoplasmic transcripts, we used oligo-dT priming in the reverse transcription reaction.
###end p 43
###begin title 44
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TFEB</italic>
Alternative 5' exons of the TFEB gene and their occurrence in different tissues
###end title 44
###begin title 45
ACKNOWLEDGEMENTS
###end title 45
###begin p 46
The authors thank L. van der Logt, A. C. Poirters and E. M. Evers for technical assistance and advice. This work was supported by a grant from the Dutch Cancer Society (Koningin Wilhelmina Fonds), KUN 99-1912.
###end p 46
###begin title 47
REFERENCES
###end title 47

